Evidence map›Paper›PMID 12724419›Full record

ArticleMolecular and cellular biology2003

Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.

Feng X Li, Jing W Zhu, Christopher J Hogan, James DeGregori

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. RNAi-mediated knockdown ofOncology letters · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Feng X LiDepartment of Biochemistry and Molecular Genetics, Division of Medical Oncology, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, CO 80262, USA.
Jing W Zhu
Christopher J Hogan
James DeGregori
University of Colorado Health · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
SPECIFIC ROLES FOR E2F FAMILY MEMBERSR01CA077314 · NCI · UNIVERSITY OF COLORADO DENVER · PI DEGREGORI, JAMES V. · 1998 to 2007
$1.8M
HUMAN HEMATOPOIETIC PRECURSOR CELLSR01HL061382 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI HOGAN, CHRISTOPHER J · 1999 to 2005
$1.8M
NCI NIH HHS 2P30 CA 46934-09NCI NIH HHS CA 77314NCI NIH HHS P30 CA046934NCI NIH HHS R01 CA077314NHLBI NIH HHS 2R01 HL 61382-04NHLBI NIH HHS R01 HL061382
6 · The paper itself

Abstract

E2F plays critical roles in cell cycle progression by regulating the expression of genes involved in nucleotide synthesis, DNA replication, and cell cycle control. We show that the combined loss of E2F1 and E2F2 in mice leads to profound cell-autonomous defects in the hematopoietic development of multiple cell lineages. E2F2 mutant mice show erythroid maturation defects that are comparable with those observed in patients with megaloblastic anemia. Importantly, hematopoietic defects observed in E2F1/E2F2 double-knockout (DKO) mice appear to result from impeded S phase progression in hematopoietic progenitor cells. During DKO B-cell maturation, differentiation beyond the large pre-BII-cell stage is defective, presumably due to failed cell cycle exit, and the cells undergo apoptosis. However, apoptosis appears to be the consequence of failed maturation, not the cause. Despite the accumulation of hematopoietic progenitor cells in S phase, the combined loss of E2F1 and E2F2 results in significantly decreased expression and activities of several E2F target genes including cyclin A2. Our results indicate specific roles for E2F1 and E2F2 in the induction of E2F target genes, which contribute to efficient expansion and maturation of hematopoietic progenitor cells. Thus, E2F1 and E2F2 play essential and redundant roles in the proper coordination of cell cycle progression with differentiation which is necessary for efficient hematopoiesis.

Indexed as

Cell Cycle ProteinsDNA-Binding ProteinsAnimalsApoptosisBlotting, WesternBone Marrow CellsBone Marrow TransplantationBromodeoxyuridineCell CycleCell DifferentiationCell LineageE2F1 Transcription FactorE2F Transcription FactorsErythropoiesisFlow CytometryGenotypeBromodeoxyuridineCell Cycle ProteinsDNA-Binding ProteinsE2f1 protein, mouseE2F1 Transcription FactorE2F Transcription FactorsGreen Fluorescent ProteinsLuminescent ProteinsTranscription Factors

Identifiers

PMID12724419
PMCPMC164755
OpenAlexW2111142380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.